{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:04:21Z","timestamp":1783087461036,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jad.2022.05.027","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:17:58Z","timestamp":1652141878000},"page":"223-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia"],"prefix":"10.1016","volume":"310","author":[{"given":"Wei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Mei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hui","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xin","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Wang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.05.027_bb0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/YCT.0000000000000632","article-title":"Effects of ketamine anesthesia on efficacy, tolerability, seizure response, and neurocognitive outcomes in electroconvulsive therapy: a comprehensive meta-analysis of double-blind randomized controlled trials","volume":"36","author":"Ainsworth","year":"2020","journal-title":"J. ECT"},{"issue":"Suppl. 1","key":"10.1016\/j.jad.2022.05.027_bb0010","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1590\/S1516-44462009000500005","article-title":"Electroconvulsive therapy in major depression: current aspects","volume":"31","author":"Antunes","year":"2009","journal-title":"Braz. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/acps.13054","article-title":"Improvement after two sessions of electroconvulsive therapy predicts final remission in in-patients with major depression","volume":"140","author":"Birkenhager","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2022.05.027_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.562137","article-title":"The combination of propofol and ketamine does not enhance clinical responses to electroconvulsive therapy in major depression-the results from the KEOpS study","volume":"11","author":"Brunelin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2022.05.027_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jad.2020.09.056","article-title":"Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression","volume":"278","author":"Delfino","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/bjp.2017.28","article-title":"Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis","volume":"212","author":"van Diermen","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpsychires.2019.07.009","article-title":"Can psychomotor disturbance predict ECT outcome in depression?","volume":"117","author":"van Diermen","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.05.027_bb0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brs.2017.10.010","article-title":"Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression","volume":"11","author":"Feffer","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.jad.2022.05.027_bb0050","first-page":"322","article-title":"Response to first ECT in depression: a predictor of outcome","volume":"40","author":"Gupta","year":"1998","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0060","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4088\/JCP.14r09528","article-title":"Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors","volume":"76","author":"Haq","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.05.027_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2147\/NDT.S248190","article-title":"BDNF and the antidepressant effects of ketamine and propofol in electroconvulsive therapy: a preliminary study","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2022.05.027_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4088\/JCP.v65n0406","article-title":"Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report","volume":"65","author":"Husain","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/JCP.0000000000001289","article-title":"Comparison of rapid antidepressant and antisuicidal effects of intramuscular ketamine, oral ketamine, and electroconvulsive therapy in patients with major depressive disorder: a pilot study","volume":"40","author":"Kheirabadi","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2022.05.027_bb0085","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1017\/S0033291716000064","article-title":"Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories","volume":"46","author":"Kishimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2022.05.027_bb0090","article-title":"Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of randomised controlled trials","volume":"33","author":"Li","year":"2020","journal-title":"Gen Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.euroneuro.2015.12.019","article-title":"Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy","volume":"26","author":"Lin","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2022.05.027_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110126","article-title":"Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: results from the Canadian rapid treatment Center of Excellence","volume":"105","author":"Lipsitz","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jad.2018.03.014","article-title":"Early improvement as a predictor of final remission in major depressive disorder: new insights in electroconvulsive therapy","volume":"235","author":"Mart\u00ednez-Amor\u00f3s","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0110","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/ajp.141.8.1010b","article-title":"Recovery from depression after one ECT","volume":"141","author":"Rich","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0115","doi-asserted-by":"crossref","DOI":"10.17795\/ijpbs-1578","article-title":"Antidepressant effect of combined ketamine and electroconvulsive therapy on patients with major depressive disorder: a randomized trial","volume":"9","author":"Shams Alizadeh","year":"2015","journal-title":"Iran. J. Psychiatry Behav. Sci."},{"key":"10.1016\/j.jad.2022.05.027_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0019-5049.135037","article-title":"Ketofol-dexmedetomidine combination in ECT: a punch for depression and agitation","volume":"58","author":"Shams","year":"2014","journal-title":"Indian J. Anaesth."},{"key":"10.1016\/j.jad.2022.05.027_bb0125","article-title":"Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder","volume":"8","author":"Sorri","year":"2018","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2022.05.027_bb0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4088\/JCP.07m03780","article-title":"Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients","volume":"70","author":"Szegedi","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/YCT.0b013e31824d1d02","article-title":"Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder","volume":"28","author":"Wang","year":"2012","journal-title":"J. ECT"},{"key":"10.1016\/j.jad.2022.05.027_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109888","article-title":"Improved and residual functional abnormalities in major depressive disorder after electroconvulsive therapy","volume":"100","author":"Wang","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpsychires.2020.03.009","article-title":"Predicting antidepressant response through early improvement of individual symptoms of depression incorporating baseline characteristics of patients: an individual patient data meta-analysis","volume":"125","author":"Watanabe","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.05.027_bb0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2022.05.027_bb0155","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jad.2019.03.071","article-title":"A preliminary study of anti-suicidal efficacy of repeated ketamine infusions in depression with suicidal ideation","volume":"251","author":"Zhan","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112907","article-title":"Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression","volume":"287","author":"Zhang","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2022.05.027_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.05.027_bb0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jad.2019.02.044","article-title":"Adjunctive ketamine and electroconvulsive therapy for major depressive disorder: a meta-analysis of randomized controlled trials","volume":"250","author":"Zheng","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2020.01.002","article-title":"Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies","volume":"265","author":"Zheng","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jad.2021.12.105","article-title":"Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression","volume":"300","author":"Zheng","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jad.2016.05.011","article-title":"Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression","volume":"201","author":"Zhong","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2022.05.027_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1775","article-title":"Subanesthetic dose of ketamine for the antidepressant effects and the associated cognitive impairments of electroconvulsive therapy in elderly patients-a randomized, double-blind, controlled clinical study","volume":"11","author":"Zou","year":"2021","journal-title":"Brain Behav."},{"key":"10.1016\/j.jad.2022.05.027_bb0195","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41398-019-0491-9","article-title":"Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome","volume":"9","author":"van Zutphen","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722005286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722005286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:08:49Z","timestamp":1759028929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722005286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":39,"alternative-id":["S0165032722005286"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.05.027","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early improvement as a predictor of final remission in patients with treatment-resistant depression receiving electroconvulsive therapy with ketofol anesthesia","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.05.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}